{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2020"],"condition":["OGIB, Small bowel stenosis, small bowel tumor, inflammatory bowel disease","OGIB, small intestine, inflammatory bowel disease, small intestine endoscope"],"disease":["Ogib, Small Intestine, Inflammatory Bowel Disease, Small Intestine Endoscope","Ogib, Small Bowel Stenosis, Small Bowel Tumor, Inflammatory Bowel Disease"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2614340"],"study_start_month":["4"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"Randomized controlled trial examining the usefulness and safety of midazolam continuous intravenous infusion and pethidine hydrochloride in small intestine endoscope","description":"Interventions: Midazolam single intravenous + pethidine hydrochloride combination\nMidazolam continuous intravenous infusion + pethidine hydrochloride combination;Midazolam single intravenous, Midazolam continuous intravenous infusion\nPrimary outcome(s): Proper sedation rate\nStudy Design: randomized controlled trial, double blind, active control, parallel assignment, treatment purpose","dates":{"creation":"2020-04-15"},"accession":"2614340","cross_references":{"Japan Primary Registries Network":["JPRN-jRCTs031200018"]}}